NCT02641054View on ClinicalTrials.gov

Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

July 31, 2017

Conditions

Idiopathic Parkinson Disease

Interventions

DRUG

CVXL-0107

DRUG

Placebo

DRUG

Levodopa

Trial Locations (1)

94700

Clevexel Pharma, Maisons-Alfort

Sponsors

Lead Sponsor

CleveXel Pharma

All Listed Sponsors

lead

CleveXel Pharma

INDUSTRY